Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Non-Current Assets: 2017-2020

Historic Non-Current Assets for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $6.0 million.

  • Cogent Biosciences' Non-Current Assets rose 22.11% to $7.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $7.9 million, marking a year-over-year increase of 22.11%. This contributed to the annual value of $6.0 million for FY2020, which is 32.02% down from last year.
  • Per Cogent Biosciences' latest filing, its Non-Current Assets stood at $6.0 million for FY2020, which was down 32.02% from $8.8 million recorded in FY2019.
  • Over the past 5 years, Cogent Biosciences' Non-Current Assets peaked at $8.8 million during FY2019, and registered a low of $4.9 million during FY2018.
  • Moreover, its 3-year median value for Non-Current Assets was $6.0 million (2020), whereas its average is $6.6 million.
  • As far as peak fluctuations go, Cogent Biosciences' Non-Current Assets soared by 79.33% in 2019, and later tumbled by 32.02% in 2020.
  • Yearly analysis of 4 years shows Cogent Biosciences' Non-Current Assets stood at $6.7 million in 2017, then fell by 26.89% to $4.9 million in 2018, then skyrocketed by 79.33% to $8.8 million in 2019, then tumbled by 32.02% to $6.0 million in 2020.